trial · primary record
Talquetamab
Multiple Myeloma
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 864 |
| Primary completion | 2028-05-25 |
| Primary endpoint | Progression-Free Survival (PFS) |
| Registry ID | NCT05455320 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:54.202Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05455320
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Talquetamab · compound